Page 3924 - Week 11 - Wednesday, 25 September 2019
Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video
(a) spasticity related to multiple sclerosis;
(b) nausea and vomiting related to chemotherapy treatment for cancer;
(c) pain or anxiety related to the active malignancy of a life limiting disease with a life expectancy that is reasonably expected to be 12 months or less;
(d) any other condition the chief health officer approves, in writing, for the prescribing of medicinal cannabis.
5
Proposed new clause 8A
Page 6, line 6—
insert
8A New section 171BA
in part 10, insert
171BA Guidance material
(1) The Minister must prepare and publish guidance material to inform the community about the legal and health implications of the amendments of this part made by the Drugs of Dependence (Personal Cannabis Use) Amendment Act 2019.
(2) The guidance material is a notifiable instrument.
Note A notifiable instrument must be notified under the Legislation Act.
6
Proposed new clause 8B
Page 6, line 6—
insert
8B New part 12
insert
Part 12 Cannabis advisory council
198 Establishment of cannabis advisory council
The cannabis advisory council is established.
199 Functions of cannabis advisory council
The council has the following functions:
(a) advising the Minister about—
(i) issues arising from the exceptions created for people 18 years old and older from offences relating to cultivating and possessing cannabis in the ACT; and
(ii) emerging or urgent cannabis issues; and
(iii) cannabis reforms and policy; and
(iv) further cannabis legislative change; and
(v) anything else in relation to cannabis requested by the Minister;
(b) any other function given to the council under this Act or another territory law.
200 Membership of cannabis advisory council
(1) The council is made up of at least 5, and not more than 7, members appointed by the Minister.
Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video